Actinomadura madurae, an aerobic actinomycete of the order Actinomycetales, inhabits soil worldwide and has been well known as a cause of actinomycotic mycetomas (11) . Recently, however, A. madurae-induced peritonitis has been reported in a patient undergoing long-term ambulatory peritoneal dialysis (13) . To our knowledge, this species has not been reported to cause either invasive pulmonary or disseminated infection in humans. We describe our experience with a patient with AIDS with pneumonia caused byA. madurae and review the microbiology and biochemical characteristics of this aerobic actinomycete.
A 39-year-old white man with an 8-year history of intravenous heroin abuse presented in January 1987 with esophageal candidiasis and was found to be human immunodeficiency virus type Histologic examination showed intra-and extracellular short filaments on the Gomori methenamine-stained section of lung, and gram-positive short filaments were also seen on the Brown and Brenn-stained preparation (Fig. 1) .
A. madurae is a mesophilic, gram-positive, non-acid-fast, aerobic actinomycete with a branched substrate and an aerial mycelium. Its primary reservoir is soil. The microorganism's pathogenic potential was first recognized in 1894 by Vincent, who named it Streptothnx madurae and described it as the causative agent of "Madura foot" (12) . In 1896, Blanchard transferred it to the genus Nocardia as Nocardia madurae (4 (1) . Also, these authors were clearly able to distinguish the genus Actinomadura from Nocardiopsis dassonvillei by using numerical data.
A. madurae is a frequent cause of actinomycotic mycetomas, superficial and/or deep suppurating tumefactions of the skin and subcutaneous tissues that result from soil contamination of a penetrating wound and usually involve the lower extremities. In mycetomas, the etiologic agents occur in the form of granules. The majority of the reports of infections by this species are from tropical and subtropical countries. However, the higher incidence and prevalence of such infections in warm climates may be only a reflection of the increased tendency for people in those areas to walk barefoot. We are aware of only one recent report of a nonmycetomic infection with this microorganism, i.e., a case of A. madurae peritonitis that developed in a patient undergoing long-term ambulatory peritoneal dialysis who had no history of travel to tropical regions. This infection responded to intraperitoneal therapy with amikacin (13). To our knowledge, there have been no reports of either invasive pulmonary or disseminated A. madurae infections.
A recent review of the aerobic actinomycete species identified by the Actinomycete Laboratory of the Centers for Disease Control from October 1985 through February 1988 from clinical specimens found that A. madurae accounted for 42 (11.5%) of 366 of the referred isolates and was second in frequency only to Nocardia asteroides, which accounted for 98 (26.8%) of 366 of these isolates (8) . In this study, we found that the majority of these isolates were from sputum (24 isolates; 57.1%) and wounds (13 isolates; 31%). One (2.4%) of the 42 isolates was a blood isolate, which supports the role ofA. madurae as a potential colonizer or infectious microorganism in some patients.
The finding that A. madurae, usually an agent of mycetomas, was an opportunistic pathogen capable of causing serious life-threatening infection in a severely immunocompromised patient suggests that clinical laboratories become proficient in the identification of this opportunistic actinomycete. The physiologic characteristics helpful in differentiating A. madurae from A. pelletieri and species in related genera are given in Table 1 . The recent finding that aerobic actinomycete isolates from clinical specimens have demonstrated inter-and intraspecies variability on antimicrobial susceptibility tests supports the need to perform antimicrobial susceptibility tests on such isolates so that more-effective antimicrobial therapy may be instituted (8) .
In our patient with underlying AIDS, histologic examination confirmed opportunistic disseminated cytomegalovirus infection, A. madurae-induced pneumonia, and secondary bacteremia. Of note, there was also evidence of persistence of the A. madurae-induced pneumonia despite antimicrobial therapy with many drugs to which his A. madurae blood isolate demonstrated in vitro susceptibility. Thus, A. madurae is a potential pathogen in AIDS patients, and in these heavily immunosuppressed patients, it may be a cause of life-threatening infection.
